Table 2.
Symptoms and laboratory findings in patients with intestinal BD according to MDS.
| Intestinal BD with MDS (n = 10) | Intestinal BD without MDS (n = 94) | P | |
|---|---|---|---|
| Age at diagnosis of intestinal BD (years) | 49.5 ± 12.8 | 37.7 ± 13.7 | 0.008∗ |
| Male (%) | 2 (20.0) | 54 (57.4) | 0.041∗ |
| Duration (months) | 178 ± 58 | 107 ± 126 | 0.129 |
| Systemic signs | |||
| Oral ulcer | 10 (100) | 90 (95.7) | >0.99 |
| Genital ulcer | 8 (80.0) | 66 (70.2) | 0.708 |
| Ocular lesion | 0 (0) | 3 (3.2) | >0.99 |
| Arthritis | 3 (30.0) | 22 (23.4) | 0.694 |
| Skin lesions | 4 (40.0) | 42 (44.7) | >0.99 |
| Positive pathergy test | 3 (30.0) | 20 (21.3) | 0.608 |
| Central nervous system | 0 (0) | 0 (0) | - |
| Symptoms of GI involvement | |||
| Abdominal pain | 7 (70.0) | 82 (87.2) | 0.184 |
| Melena/hematochezia | 4 (40.0) | 30 (31.9) | 0.717 |
| Diarrhea | 5 (50.0) | 46 (48.9) | >0.99 |
| Weight loss | 8 (80.0) | 44 (46.8) | 0.083 |
| Fever | 6 (60.0) | 8 (8.5) | 0.002∗ |
| Perforation | 0 (0) | 8 (8.5) | >0.99 |
| Ileus | 1 (10.0) | 8 (8.5) | >0.99 |
| Location of intestinal ulcers | |||
| Esophagus | 0 (0) | 18 (19.1) | 0.336 |
| Ileocecal | 9 (90.0) | 46 (48.9) | 0.032∗ |
| Small intestine | 1 (10.0) | 6 (6.4) | 0.548 |
| Colon | 1 (10.0) | 24 (25.5) | 0.426 |
| Laboratory findings at BD diagnosis | |||
| CRP (mg/L) | 63.3 ± 41.4 | 20.7 ± 28.4 | 0.010∗ |
| ESR (mm/h) | 91.9 ± 21.5 | 129.4 ± 21.9 | <0.001∗ |
| WBC (109/L) | 3.7 ± 2.5 | 6.8 ± 2.9 | 0.003∗ |
| Hemoglobin (g/L) | 89.7 ± 17.7 | 129.4 ± 19.9 | <0.001∗ |
| Platelets (109/L) | 163.9 ± 116.4 | 243.1 ± 92.7 | 0.023∗ |
∗ P < 0.05. BD: Behçet disease; GI: gastrointestinal; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; WBC: white blood cells.